Upper Galilee, Israel

Idan Naaman

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Idan Naaman. Retrieved from https://idiyas.com/inventor/idan-naaman-f2d6f1ec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Idan Naaman: Inventor in Medical Injection Technology.

Introduction

Idan Naaman is an inventor associated with Upper Galilee, Israel, and Pfizer Corporation. His work includes an invention designed to improve needle concealment in injectors.

Latest Patents

Naaman is credited with 1 patent: “System and Method for Needle Hiding in Injectors.” The patent describes an injector with a housing that receives a medicament cartridge, a drive mechanism that advances the cartridge piston to deliver medication, and a sliding needle-hiding element. The element can extend forward from the housing or retract and lock relative to it.

Career Highlights

Naaman’s patent focuses on an injector design that incorporates a movable element to conceal the needle. This mechanism is intended to provide distinct extended and retracted positions as part of the device’s operation.

Collaborations

Naaman’s listed coworkers include Ilan Kachler and Amotz Porat. The available information identifies his association with Pfizer Corporation but does not specify the details of these collaborations.

Conclusion

Idan Naaman’s recorded invention addresses needle concealment in injectors through a sliding, positionable component, reflecting his contribution to medical-device innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…